Redwood Bioscience, Inc. is utilizing precision protein-chemical engineering to optimize conjugate therapeutics. Leveraging libraries of site-specifically modified protein scaffolds, the Company is focused on developing enhanced antibody-drug conjugates and peptide therapeutics.